Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

0.715
0.000
Volume:10.40M
Turnover:7.52M
Market Cap:6.52B
PE:36.29
High:0.730
Open:0.720
Low:0.715
Close:0.715
52wk High:1.896
52wk Low:0.685
Shares:9.12B
HK Float Shares:9.12B
Volume Ratio:1.30
T/O Rate:0.11%
Dividend:0.01
Dividend Rate:1.57%
EPS(LYR):0.020
ROE:5.57%
ROA:2.80%
PB:0.91
PE(LYR):36.29
PS:2.11

Loading ...

Sihuan Pharma Unit Gets China Nod for Five New Specifications of Skin Booster

MT Newswires Live
·
Oct 05

SIHUAN PHARM (00460): Additional Specifications of "Dongyan" Skin Booster Approved for Market Launch by National Medical Products Administration

Stock News
·
Oct 05

Sihuan Pharma - Five New Specifications of Dongyan Skin Booster Approved for Launch by Nmpa

THOMSON REUTERS
·
Oct 05

Sihuan Pharmaceutical Announces Release of Interim Report 2026 and Details Shareholder Communication Procedures

Bulletin Express
·
Sep 16

SIHUAN PHARM Publishes 2026 Interim Report and Updates Shareholder Communication Arrangements

Bulletin Express
·
Sep 16

SIHUAN PHARM Subsidiary Xuanzhu Biopharm Seals Thailand Deal Granting Innobic Exclusive Rights to Commercialise Bireociclib Until 2036

Bulletin Express
·
Sep 03

Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets

Reuters
·
Sep 03

Sihuan Pharma Grants 116,150,000 Share Awards Under 2026 Incentive Scheme at HK$ 0.74 Each

Reuters
·
Sep 01

Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches

Simply Wall St.
·
Aug 27

Sihuan Pharmaceutical Announces HK$8.11 Million Share Buy-Back; H1 2026 Net Profit Surges 221%

Bulletin Express
·
Aug 27

SIHUAN PHARM Repurchases 10 Million Shares for HK$8.11 Million, Lifting Treasury Stock to 214 Million

Bulletin Express
·
Aug 27

Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81

Reuters
·
Aug 27

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

Reuters
·
Aug 26

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Reuters
·
Aug 26

Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion

Reuters
·
Aug 26

Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List

Reuters
·
Aug 26

SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy

Stock News
·
Aug 26

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Reuters
·
Aug 26

Sihuan Pharmaceutical’s H1 2026 Net Profit Jumps 119% to RMB224.70 Million as Aesthetics and Innovative Drugs Offset Generic Slump

Bulletin Express
·
Aug 26

Sihuan Pharmaceutical Holdings Group H1 Net Income Attributable RMB 224.7 Million

THOMSON REUTERS
·
Aug 26